TAE Life Sciences (TLS) has signed a letter of intent with the OSUCCC – James to develop boron-based drug compounds for ...

China NMPA's Center for Drug Evaluation (CDE) has granted priority review for InnoCare Pharma's zurletrectinib (ICP-723) ...

The US FDA has accepted Novo Nordisk’s new drug application (NDA) submission for the 25 mg oral formulation of Wegovy ...

The US HHS has launched a $500m initiative to accelerate the development of universal vaccines targeting viruses with ...

Logistics providers can considerably ease the challenges of transporting essential and time-sensitive medicines along pharma ...

The FDA has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with giant cell arteritis (GCA).

J&J's Imaavy (nipocalimab-aahu) has received US Food and Drug Administration (FDA) approval for treating generalised ...

As scientists explore treating genetic disorders before birth, the promise of foetal gene therapy is growing—but there are ...

Eli Lilly’s strong quarterly results were overshadowed by CVS’s decision to favour Novo Nordisk’s Wegovy over Zepbound.

D Molecular Therapeutics (4DMT) has received the regenerative medicine advanced therapy (RMAT) designation from the FDA for ...

The UK MHRA has granted marketing authorisation to Bavarian Nordic's Vimkunya vaccine for preventing the chikungunya virus.

Data from the NERO study investigating Zejula in mesothelioma was presented at the American Association of Cancer Research ...